Product NDC: | 36000-175 |
Proprietary Name: | Nafcillin |
Non Proprietary Name: | Nafcillin |
Active Ingredient(s): | 1 g/1 & nbsp; Nafcillin |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 36000-175 |
Labeler Name: | Claris Lifesciences, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090560 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120201 |
Package NDC: | 36000-175-10 |
Package Description: | 10 VIAL in 1 PACKAGE (36000-175-10) > 1 INJECTION in 1 VIAL (36000-175-01) |
NDC Code | 36000-175-10 |
Proprietary Name | Nafcillin |
Package Description | 10 VIAL in 1 PACKAGE (36000-175-10) > 1 INJECTION in 1 VIAL (36000-175-01) |
Product NDC | 36000-175 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Nafcillin |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20120201 |
Marketing Category Name | ANDA |
Labeler Name | Claris Lifesciences, Inc. |
Substance Name | NAFCILLIN SODIUM |
Strength Number | 1 |
Strength Unit | g/1 |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] |